Requests that the FDA declare that the drug product, norethindrone acetate 1 mg / ethinyl estradiol 15 mcg capsules and ferrous fumarate 75 mg capsules, is suitable for submission in an Abbreviated New Drug Application.
FDA-2026-P-7276
Documents
5
Total comments
0
all analyzed
Comment status
Open
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
- Other· Jun 30, 2026No comment period
- Supporting & Related Material· Jun 30, 2026
- Supporting & Related Material· Jun 30, 2026